Staff Physician
BIOGRAPHY
JAN 25, 2023 8:00 AM PST
Multiplex proteomics using proximity extension assay for identification of protein biomarkers predictive of acute graft-versus-host disease in allogeneic hematopoietic cell transplantation
Speakers
-
Dr. Frank (Fotios) Michelis
Hans Messner Allogeneic Transplant Program Division of Medical Oncology & Hematology Princess Margaret Cancer Centre Assistant Professor Department of Medicine University of Toronto
Event Date & Time
Date: January 25, 2023
Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET)
Abstract
Allogeneic hematopoietic cell transplantation (HCT) is curative for hematological diseases; however, is also associated with complications such as acute graft-vs-host disease (aGVHD). In this study we describe the use of multiplex antibody-based proximity extension assay (PEA) proteomic platform to identify novel biomarkers of aGVHD in a cohort of patients who received allogeneic HCT for acute myeloid leukaemia (AML).
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
DEC 12, 2023 15:00 CET
C.E. CREDITS
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 25, 2024
- See More
